1-21570274-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B.
The NM_000478.6(ALPL):c.793-31C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 1,610,114 control chromosomes in the GnomAD database, including 21,467 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1609 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19858 hom. )
Consequence
ALPL
NM_000478.6 intron
NM_000478.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.10
Publications
26 publications found
Genes affected
ALPL (HGNC:438): (alkaline phosphatase, biomineralization associated) This gene encodes a member of the alkaline phosphatase family of proteins. There are at least four distinct but related alkaline phosphatases: intestinal, placental, placental-like, and liver/bone/kidney (tissue non-specific). The first three are located together on chromosome 2, while the tissue non-specific form is located on chromosome 1. The product of this gene is a membrane bound glycosylated enzyme that is not expressed in any particular tissue and is, therefore, referred to as the tissue-nonspecific form of the enzyme. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature enzyme. This enzyme may play a role in bone mineralization. Mutations in this gene have been linked to hypophosphatasia, a disorder that is characterized by hypercalcemia and skeletal defects. [provided by RefSeq, Oct 2015]
ALPL Gene-Disease associations (from GenCC):
- adult hypophosphatasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
- childhood hypophosphatasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
- hypophosphatasiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
- infantile hypophosphatasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
- odontohypophosphatasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- perinatal lethal hypophosphatasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-21570274-C-T is Benign according to our data. Variant chr1-21570274-C-T is described in ClinVar as [Benign]. Clinvar id is 256232.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALPL | NM_000478.6 | c.793-31C>T | intron_variant | Intron 7 of 11 | ENST00000374840.8 | NP_000469.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.141 AC: 21420AN: 152068Hom.: 1602 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21420
AN:
152068
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.162 AC: 40526AN: 250202 AF XY: 0.166 show subpopulations
GnomAD2 exomes
AF:
AC:
40526
AN:
250202
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.163 AC: 237261AN: 1457928Hom.: 19858 Cov.: 31 AF XY: 0.164 AC XY: 119111AN XY: 725528 show subpopulations
GnomAD4 exome
AF:
AC:
237261
AN:
1457928
Hom.:
Cov.:
31
AF XY:
AC XY:
119111
AN XY:
725528
show subpopulations
African (AFR)
AF:
AC:
3223
AN:
33390
American (AMR)
AF:
AC:
6220
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
AC:
5746
AN:
26106
East Asian (EAS)
AF:
AC:
7077
AN:
39658
South Asian (SAS)
AF:
AC:
17481
AN:
86116
European-Finnish (FIN)
AF:
AC:
5788
AN:
53272
Middle Eastern (MID)
AF:
AC:
1182
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
180543
AN:
1108734
Other (OTH)
AF:
AC:
10001
AN:
60268
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
10901
21802
32702
43603
54504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6432
12864
19296
25728
32160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.141 AC: 21437AN: 152186Hom.: 1609 Cov.: 32 AF XY: 0.139 AC XY: 10348AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
21437
AN:
152186
Hom.:
Cov.:
32
AF XY:
AC XY:
10348
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
3943
AN:
41520
American (AMR)
AF:
AC:
2257
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
778
AN:
3470
East Asian (EAS)
AF:
AC:
930
AN:
5174
South Asian (SAS)
AF:
AC:
898
AN:
4826
European-Finnish (FIN)
AF:
AC:
1122
AN:
10596
Middle Eastern (MID)
AF:
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10863
AN:
68002
Other (OTH)
AF:
AC:
348
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
947
1893
2840
3786
4733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
621
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Infantile hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Adult hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Childhood hypophosphatasia Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.